Francis Rooney bought Cigna Corp (NYSE: CI)
Francis Rooney (R-FL), a U.S. Representative, has disclosed 1 trade in Cigna Corp (CI) since 2018, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Francis Rooney bought $1,000 - $15,000 of Cigna Corp (NYSE: CI) on March 27, 2018. Since that trade, CI is up +96.93% against the S&P 500 up +216.76%, an outperformance of -119.83%.
Data updated
Francis Rooney's CI trades vs the price
CI is up +96.93% since Francis Rooney bought on March 27, 2018, versus +216.76% for the S&P 500.
Performance since this trade
All Francis Rooney CI trades
Francis Rooney & CI trading FAQ
Is it legal for Francis Rooney to trade Cigna Corp (CI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Cigna Corp (CI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Francis Rooney buy CI?
Francis Rooney disclosed a purchase of $1,000 - $15,000 of Cigna Corp (CI) on March 27, 2018, according to public STOCK Act filings.
How has CI performed since Francis Rooney's trade?
Since Francis Rooney bought CI on March 27, 2018, the stock is up +96.93%, versus +216.76% for the S&P 500 over the same period, an outperformance of -119.83%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CI trades?
Quantellect tracks every disclosed congressional trade in Cigna Corp (CI) on the Cigna Corp congressional trading page, which aggregates filings across all members of Congress.
Francis Rooney's CI tradesAll congressional filings for Cigna CorpFrancis Rooney's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.